Related references
Note: Only part of the references are listed.The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases
Rainer J. Klement et al.
BMC CANCER (2019)
Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition)
Jian Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Outcomes after hypofractionated stereotactic radiotherapy for colorectal cancer oligometastases
Jing Yu et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapy
Ciro Franzese et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer Prognostic Factors for Disease Control and Survival
Haoming Qiu et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)
Survival Benefit of Palliative Local Treatments and Efficacy of Different Pharmacotherapies in Colorectal Cancer With Lung Metastasis: Results From a Large Retrospective Study
Zhenghang Wang et al.
CLINICAL COLORECTAL CANCER (2018)
Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT
Yasutaka Ogawa et al.
RADIATION ONCOLOGY (2018)
Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis
Keiichi Jingu et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2018)
Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter
Joelle Helou et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2016)
Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83-100 Gy in five fractions
Atsuya Takeda et al.
JOURNAL OF RADIATION RESEARCH (2016)
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
Joe Y. Chang et al.
LANCET ONCOLOGY (2015)
Tumor Response on CT Following Hypofractionated Stereotactic Ablative Body Radiotherapy for Small Hypervascular Hepatocellular Carcinoma With Cirrhosis
Naoko Sanuki et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2013)
Lung Metastases Treated with Image-guided Stereotactic Body Radiation Therapy
A. M. Baschnagel et al.
CLINICAL ONCOLOGY (2013)
The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study
Abhishek A. Solanki et al.
RADIATION ONCOLOGY (2012)
Treatment recommendations for metastatic colorectal cancer
Enrique Aranda et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
CONSIDERATION OF DOSE LIMITS FOR ORGANS AT RISK OF THORACIC RADIOTHERAPY: ATLAS FOR LUNG, PROXIMAL BRONCHIAL TREE, ESOPHAGUS, SPINAL CORD, RIBS, AND BRACHIAL PLEXUS
Feng-Ming (Spring) Kong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
The role of local therapy in the management of lung and liver oligometastases
Simon S. Lo et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Oligometastases revisited
Ralph R. Weichselbaum et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
21 years of Biologically Effective Dose
J. F. Fowler
BRITISH JOURNAL OF RADIOLOGY (2010)
Oligometastases confined one organ from colorectal cancer treated by SBRT
Jin-Kyu Kang et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study
Emmanuel Mitry et al.
GUT (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
DOSIMETRIC EVALUATION OF HETEROGENEITY CORRECTIONS FOR RTOG 0236: STEREOTACTIC BODY RADIOTHERAPY OF INOPERABLE STAGE I-II NON-SMALL-CELL LUNG CANCER
Ying Xiao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Extending the frontiers of surgical therapy for hepatic colorectal metastases: Is there a limit?
VP Khatri et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Share Paper
